Jefferies Stays on Sidelines with Myriad (MYGN) after DNA Ruling
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
| Myriad Genetics, Inc. (NASDAQ: MYGN) | Delayed: 6.02 +0.20 (3.44%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.82 | 52 Week High | $45.34 | |||
| Open | $5.82 | 52 Week Low | $15.92 | |||
| Day High | $6.07 | P/E | 2.58 | |||
| Day Low | $5.78 | EPS | $2.33 | |||
| Volume | 1,486,650 | |||||
